Valuation: DexCom, Inc.

Capitalization 2.37TCr 2.01TCr 1.85TCr 1.74TCr 3.25TCr 2,20800Cr 3.31TCr 22TCr 8.49TCr 1,06000Cr 8.89TCr 8.7TCr 3,76300Cr P/E ratio 2026 *
25.2x
P/E ratio 2027 * 20.7x
Enterprise value 2.33TCr 1.97TCr 1.82TCr 1.72TCr 3.2TCr 2,17300Cr 3.25TCr 21TCr 8.36TCr 1,04300Cr 8.74TCr 8.56TCr 3,70300Cr EV / Sales 2026 *
4.46x
EV / Sales 2027 * 3.82x
Free-Float
95.22%
Yield 2026 *
-
Yield 2027 * -
1 day-2.24%
1 week-6.47%
Current month-2.01%
1 month-4.20%
3 months-11.12%
6 months-5.92%
Current year-7.28%
1 week 61.37
Extreme 61.37
66.14
1 month 60.57
Extreme 60.57
68.76
Current year 60.57
Extreme 60.57
75.98
1 year 54.11
Extreme 54.11
89.98
3 years 54.11
Extreme 54.11
142
5 years 54.11
Extreme 54.11
164.86
10 years 10.66
Extreme 10.655
164.86
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer 49 01/10/2022
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Change 5d. change 1-year change 3-years change Capi.($)
-2.24%-6.47%-11.11%-46.81% 2.37TCr
+1.14%-1.93%-19.54%-2.31% 18TCr
-1.16%-1.75%+5.74%+7.92% 11TCr
-0.73%-2.26%+11.61%+90.02% 6.18TCr
-0.10%+3.50%+95.89%+108.70% 6.34TCr
-0.13%-1.00%-23.03%-39.13% 4.43TCr
+0.55%+8.10% - - 3.89TCr
-1.48%-1.57%+0.21%+18.75% 2.17TCr
-0.33%+8.41%-4.31%-35.73% 2.11TCr
+0.05%+0.78%-16.60%+13.02% 2.03TCr
Average -0.62%+0.61%+4.32%+12.71% 5.84TCr
Weighted average by Cap. -0.63%-0.03%+4.18%+18.36%

Financials

2026 *2027 *
Net sales 522.66Cr 442.74Cr 408.26Cr 384.97Cr 718.02Cr 49TCr 729.59Cr 4.79TCr 1.87TCr 23TCr 1.96TCr 1.92TCr 83TCr 587.64Cr 497.79Cr 459.02Cr 432.83Cr 807.29Cr 55TCr 820.3Cr 5.38TCr 2.11TCr 26TCr 2.2TCr 2.16TCr 93TCr
Net income 97Cr 82Cr 76Cr 71Cr 132.88Cr 9.02TCr 135.02Cr 886.08Cr 346.83Cr 4.33TCr 362.88Cr 355.28Cr 15TCr 118.69Cr 100.55Cr 93Cr 87Cr 163.06Cr 11TCr 165.69Cr 1.09TCr 425.62Cr 5.31TCr 445.31Cr 435.99Cr 19TCr
Net Debt -38Cr -32Cr -29Cr -28Cr -52Cr -3.52TCr -53Cr -345.59Cr -135.27Cr -1.69TCr -141.53Cr -138.56Cr -5.99TCr -123.06Cr -104.24Cr -96Cr -91Cr -169.06Cr -11TCr -171.78Cr -1.13TCr -441.28Cr -5.51TCr -461.68Cr -452.02Cr -20TCr
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
15/26/15 61.54 $ -2.24% 56,82,926
14/26/14 62.95 $ -0.27% 47,30,405
13/26/13 63.12 $ -1.41% 57,01,564
10/26/10 64.02 $ -2.53% 21,07,262
09/26/09 65.68 $ -0.18% 37,62,664
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
61.54USD
Average target price
86.88USD
Spread / Average Target
+41.17%

Quarterly revenue - Rate of surprise